Global Submissions From a Single Source of Truth
Weave Bio has expanded its platform to support global regulatory submissions from one connected source of truth. Teams can now structure filings for different health authorities while working from the same underlying program data. New dossier customization capabilities include a preloaded EU Clinical Trial Application (CTA) template.
Regulatory teams often rebuild dossiers when they prepare submissions for new jurisdictions. Weave reduces that repeated work by connecting source data across a program. Teams can draw from one verified reference set across filings and reuse previous submissions as the foundation for future regulatory activities.
What this means for regulatory teams
Drug development programs are global, but submission structures vary by jurisdiction. Weave supports those differences with customizable dossier structures. Teams can configure sections, folders, and document organization to match the requirements of different health authorities.
The platform includes a preloaded EU CTA template built to European Medicines Agency (EMA) section hierarchies. Teams can also use a custom template builder to create structures for additional markets. Weave plans to introduce more partner-developed templates for other jurisdictions in future releases.
Looking ahead
These new capabilities expand Weave’s support across the regulatory lifecycle, from INDs and CTAs to NDAs and beyond. As organizations pursue global development strategies, they can manage submissions across markets without rebuilding dossiers for every new filing.